论文部分内容阅读
目的研究分析过敏性哮喘儿童免疫治疗长期疗效观察。方法过敏性哮喘儿童100例,将患儿随机分成治疗组和对照组,每组50例。治疗组的患儿采用标准化尘螨疫苗特异性免疫治疗,对照组的患儿采用吸入舒利迭治疗。观察两组患儿治疗后的复发情况。结果对两组患儿治疗前后进行观察,治疗组患儿在进行治疗后外周嗜酸细胞计数与血tIgE的水平明显优于对照组患儿的外周嗜酸细胞计数与血tIgE水平,且治疗组患儿的复发率(16.00%)明显低于对照组患儿的复发率(42.00%),差异有统计学意义(P<0.01)。结论特异性免疫治疗对儿童过敏性哮喘有显著的疗效,较低的复发率,具有长期的临床疗效,在临床上值得广泛应用。
Objective To study the long-term efficacy of immunotherapy in children with allergic asthma. Methods 100 cases of children with allergic asthma, the children were randomly divided into treatment group and control group, 50 cases in each group. Children in the treatment group received standardized immunization with dust-mite vaccine, while those in the control group received inhaled seretide. The recurrence after treatment in both groups was observed. Results Both before and after treatment, the eosinophil count and blood tIgE levels in children in treatment group were significantly better than those in control group after treatment, and the treatment group The recurrence rate of children (16.00%) was significantly lower than that of the control group (42.00%), the difference was statistically significant (P <0.01). Conclusion Specific immunotherapy has a significant effect on children with allergic asthma, a low recurrence rate, with long-term clinical efficacy, it is widely used in clinical practice.